Annual CFF
$26.07 B
+$40.90 B+275.72%
31 December 2023
Summary:
Pfizer annual cash flow from financing activities is currently $26.07 billion, with the most recent change of +$40.90 billion (+275.72%) on 31 December 2023. During the last 3 years, it has risen by +$35.72 billion (+370.14%). PFE annual CFF is now at all-time high.PFE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$4.64 B
-$2.18 B-88.53%
30 September 2024
Summary:
Pfizer quarterly cash flow from financing activities is currently -$4.64 billion, with the most recent change of -$2.18 billion (-88.53%) on 30 September 2024. Over the past year, it has dropped by -$857.00 million (-22.68%). PFE quarterly CFF is now -117.06% below its all-time high of $27.17 billion, reached on 01 June 2023.PFE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$6.58 B
-$857.00 M-14.96%
30 September 2024
Summary:
Pfizer TTM cash flow from financing activities is currently -$6.58 billion, with the most recent change of -$857.00 million (-14.96%) on 30 September 2024. Over the past year, it has dropped by -$22.19 billion (-142.18%). PFE TTM CFF is now -125.26% below its all-time high of $26.07 billion, reached on 31 December 2023.PFE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +275.7% | -22.7% | -142.2% |
| 3 y3 years | +370.1% | -321.1% | +67.5% |
| 5 y5 years | +227.5% | -241.6% | +47.1% |
PFE Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +275.7% | -117.1% | +29.5% | -125.3% | +67.5% |
| 5 y | 5 years | at high | +227.5% | -117.1% | +66.4% | -125.3% | +70.0% |
| alltime | all time | at high | +212.8% | -117.1% | +66.4% | -125.3% | +71.5% |
Pfizer Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.64 B(+88.5%) | -$6.58 B(+15.0%) |
| June 2024 | - | -$2.46 B(-50.1%) | -$5.73 B(-124.0%) |
| Mar 2024 | - | -$4.93 B(-190.6%) | $23.91 B(-8.3%) |
| Dec 2023 | $26.07 B(-275.7%) | $5.44 B(-244.0%) | $26.07 B(+67.0%) |
| Sept 2023 | - | -$3.78 B(-113.9%) | $15.61 B(+14.5%) |
| June 2023 | - | $27.17 B(-1080.7%) | $13.63 B(-223.6%) |
| Mar 2023 | - | -$2.77 B(-44.7%) | -$11.03 B(-25.7%) |
| Dec 2022 | -$14.83 B(+51.1%) | -$5.01 B(-12.9%) | -$14.83 B(+12.6%) |
| Sept 2022 | - | -$5.76 B(-328.6%) | -$13.17 B(+54.8%) |
| June 2022 | - | $2.52 B(-138.3%) | -$8.51 B(-37.4%) |
| Mar 2022 | - | -$6.58 B(+96.3%) | -$13.59 B(+38.4%) |
| Dec 2021 | -$9.82 B(+1.7%) | -$3.35 B(+204.4%) | -$9.82 B(-51.5%) |
| Sept 2021 | - | -$1.10 B(-56.9%) | -$20.25 B(-7.8%) |
| June 2021 | - | -$2.56 B(-8.9%) | -$21.97 B(+114.2%) |
| Mar 2021 | - | -$2.81 B(-79.6%) | -$10.26 B(+6.3%) |
| Dec 2020 | -$9.65 B(+13.7%) | -$13.79 B(+388.7%) | -$9.65 B(-668.3%) |
| Sept 2020 | - | -$2.82 B(-130.8%) | $1.70 B(-78.2%) |
| June 2020 | - | $9.16 B(-516.3%) | $7.79 B(-451.3%) |
| Mar 2020 | - | -$2.20 B(-9.8%) | -$2.22 B(-73.9%) |
| Dec 2019 | -$8.48 B(-58.5%) | -$2.44 B(-174.5%) | -$8.48 B(-31.9%) |
| Sept 2019 | - | $3.27 B(-484.6%) | -$12.45 B(-27.3%) |
| June 2019 | - | -$851.00 M(-89.9%) | -$17.13 B(-5.8%) |
| Mar 2019 | - | -$8.47 B(+32.2%) | -$18.19 B(-11.0%) |
| Dec 2018 | -$20.44 B(+53.1%) | -$6.41 B(+355.7%) | -$20.44 B(+15.0%) |
| Sept 2018 | - | -$1.41 B(-26.3%) | -$17.78 B(-1.7%) |
| June 2018 | - | -$1.91 B(-82.2%) | -$18.08 B(-5.6%) |
| Mar 2018 | - | -$10.72 B(+186.4%) | -$19.16 B(+43.5%) |
| Dec 2017 | -$13.35 B(+44.7%) | -$3.74 B(+118.8%) | -$13.35 B(+12.0%) |
| Sept 2017 | - | -$1.71 B(-42.8%) | -$11.92 B(+0.4%) |
| June 2017 | - | -$2.99 B(-39.1%) | -$11.87 B(+70.5%) |
| Mar 2017 | - | -$4.91 B(+112.1%) | -$6.96 B(-24.5%) |
| Dec 2016 | -$9.23 B(-11.3%) | -$2.31 B(+39.2%) | -$9.23 B(+12.4%) |
| Sept 2016 | - | -$1.66 B(-186.7%) | -$8.21 B(+20.5%) |
| June 2016 | - | $1.92 B(-126.7%) | -$6.81 B(-35.8%) |
| Mar 2016 | - | -$7.17 B(+454.2%) | -$10.60 B(+1.9%) |
| Dec 2015 | -$10.41 B(+2.2%) | -$1.29 B(+392.0%) | -$10.41 B(-15.0%) |
| Sept 2015 | - | -$263.00 M(-86.0%) | -$12.24 B(-17.7%) |
| June 2015 | - | -$1.87 B(-73.1%) | -$14.87 B(-1.1%) |
| Mar 2015 | - | -$6.98 B(+123.2%) | -$15.03 B(+47.6%) |
| Dec 2014 | -$10.19 B(-32.0%) | -$3.13 B(+8.3%) | -$10.19 B(-20.4%) |
| Sept 2014 | - | -$2.89 B(+41.5%) | -$12.80 B(-17.6%) |
| June 2014 | - | -$2.04 B(-4.4%) | -$15.55 B(-11.4%) |
| Mar 2014 | - | -$2.13 B(-62.9%) | -$17.54 B(+17.1%) |
| Dec 2013 | -$14.97 B(-6.4%) | -$5.74 B(+2.0%) | -$14.97 B(-3.2%) |
| Sept 2013 | - | -$5.63 B(+39.6%) | -$15.46 B(+17.8%) |
| June 2013 | - | -$4.03 B(-1029.5%) | -$13.12 B(+8.8%) |
| Mar 2013 | - | $434.00 M(-107.0%) | -$12.06 B(-24.6%) |
| Dec 2012 | -$16.00 B(-22.4%) | -$6.23 B(+89.4%) | -$16.00 B(-0.1%) |
| Sept 2012 | - | -$3.29 B(+10.9%) | -$16.02 B(-4.4%) |
| June 2012 | - | -$2.97 B(-15.4%) | -$16.76 B(-5.4%) |
| Mar 2012 | - | -$3.51 B(-43.9%) | -$17.71 B(-14.1%) |
| Dec 2011 | -$20.61 B(+84.4%) | -$6.25 B(+54.9%) | -$20.61 B(+33.5%) |
| Sept 2011 | - | -$4.04 B(+3.0%) | -$15.44 B(+10.9%) |
| June 2011 | - | -$3.92 B(-38.8%) | -$13.92 B(-3.1%) |
| Mar 2011 | - | -$6.40 B(+493.5%) | -$14.37 B(+28.6%) |
| Dec 2010 | -$11.17 B(-177.2%) | -$1.08 B(-57.2%) | -$11.17 B(-12.9%) |
| Sept 2010 | - | -$2.52 B(-42.1%) | -$12.83 B(+5.7%) |
| June 2010 | - | -$4.36 B(+35.8%) | -$12.13 B(-842.1%) |
| Mar 2010 | - | -$3.21 B(+17.4%) | $1.64 B(-88.7%) |
| Dec 2009 | $14.48 B(-320.7%) | -$2.73 B(+49.6%) | $14.48 B(-3.2%) |
| Sept 2009 | - | -$1.83 B(-119.4%) | $14.96 B(+3.8%) |
| June 2009 | - | $9.41 B(-2.4%) | $14.41 B(+547.1%) |
| Mar 2009 | - | $9.63 B(-527.7%) | $2.23 B(-133.9%) |
| Dec 2008 | -$6.56 B(-48.0%) | -$2.25 B(-5.3%) | -$6.56 B(+45.6%) |
| Sept 2008 | - | -$2.38 B(-14.4%) | -$4.51 B(-29.4%) |
| June 2008 | - | -$2.78 B(-427.5%) | -$6.38 B(-7.7%) |
| Mar 2008 | - | $848.00 M(-524.0%) | -$6.91 B(-45.2%) |
| Dec 2007 | -$12.61 B | -$200.00 M(-95.3%) | -$12.61 B(-24.3%) |
| Sept 2007 | - | -$4.25 B(+28.5%) | -$16.66 B(-4.9%) |
| June 2007 | - | -$3.31 B(-31.7%) | -$17.52 B(-8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$4.85 B(+14.0%) | -$19.18 B(-17.0%) |
| Dec 2006 | -$23.10 B(+150.5%) | -$4.25 B(-16.6%) | -$23.10 B(+59.1%) |
| Sept 2006 | - | -$5.10 B(+2.5%) | -$14.52 B(+28.7%) |
| June 2006 | - | -$4.98 B(-43.2%) | -$11.28 B(-34.3%) |
| Mar 2006 | - | -$8.77 B(-302.6%) | -$17.17 B(+86.2%) |
| Dec 2005 | -$9.22 B(+39.1%) | $4.33 B(-332.3%) | -$9.22 B(-45.4%) |
| Sept 2005 | - | -$1.86 B(-82.9%) | -$16.90 B(-11.2%) |
| June 2005 | - | -$10.87 B(+1228.6%) | -$19.03 B(+110.8%) |
| Mar 2005 | - | -$818.00 M(-75.6%) | -$9.03 B(+36.2%) |
| Dec 2004 | -$6.63 B(-60.8%) | -$3.35 B(-16.2%) | -$6.63 B(-23.5%) |
| Sept 2004 | - | -$4.00 B(+360.9%) | -$8.66 B(+5.3%) |
| June 2004 | - | -$867.00 M(-154.8%) | -$8.22 B(-45.4%) |
| Mar 2004 | - | $1.58 B(-129.4%) | -$15.07 B(-10.9%) |
| Dec 2003 | -$16.91 B(+238.2%) | -$5.38 B(+51.4%) | -$16.91 B(+16.1%) |
| Sept 2003 | - | -$3.56 B(-53.9%) | -$14.57 B(+21.9%) |
| June 2003 | - | -$7.72 B(+2961.9%) | -$11.95 B(+137.3%) |
| Mar 2003 | - | -$252.00 M(-91.7%) | -$5.04 B(+0.7%) |
| Dec 2002 | -$5.00 B(+138.5%) | -$3.04 B(+223.7%) | -$5.00 B(+54.4%) |
| Sept 2002 | - | -$940.00 M(+17.4%) | -$3.24 B(+13.7%) |
| June 2002 | - | -$801.00 M(+272.6%) | -$2.85 B(+55.0%) |
| Mar 2002 | - | -$215.00 M(-83.2%) | -$1.84 B(-12.4%) |
| Dec 2001 | -$2.10 B(-43.4%) | -$1.28 B(+133.5%) | -$2.10 B(-36.8%) |
| Sept 2001 | - | -$549.00 M(-362.7%) | -$3.31 B(-0.9%) |
| June 2001 | - | $209.00 M(-144.1%) | -$3.34 B(-20.6%) |
| Mar 2001 | - | -$474.00 M(-81.0%) | -$4.21 B(+13.7%) |
| Dec 2000 | -$3.71 B(+127.7%) | -$2.50 B(+332.7%) | -$3.71 B(+41.9%) |
| Sept 2000 | - | -$578.00 M(-12.2%) | -$2.61 B(-10.8%) |
| June 2000 | - | -$658.00 M(-2156.3%) | -$2.93 B(+23.7%) |
| Mar 2000 | - | $32.00 M(-102.3%) | -$2.37 B(+45.4%) |
| Dec 1999 | -$1.63 B(-55.3%) | -$1.41 B(+57.6%) | -$1.63 B(-45.7%) |
| Sept 1999 | - | -$893.00 M(+811.2%) | -$3.00 B(+9.7%) |
| June 1999 | - | -$98.00 M(-112.7%) | -$2.73 B(-1.7%) |
| Mar 1999 | - | $771.00 M(-127.7%) | -$2.78 B(-23.6%) |
| Dec 1998 | -$3.64 B(+342.4%) | -$2.78 B(+341.8%) | -$3.64 B(+162.9%) |
| Sept 1998 | - | -$629.00 M(+336.8%) | -$1.39 B(+3.1%) |
| June 1998 | - | -$144.00 M(+61.8%) | -$1.34 B(+25.4%) |
| Mar 1998 | - | -$89.00 M(-83.0%) | -$1.07 B(+30.1%) |
| Dec 1997 | -$823.00 M(+124.3%) | -$523.00 M(-10.9%) | -$823.00 M(-30.0%) |
| Sept 1997 | - | -$587.00 M(-558.6%) | -$1.18 B(+678.1%) |
| June 1997 | - | $128.00 M(-19.5%) | -$151.00 M(+7.9%) |
| Mar 1997 | - | $159.00 M(-118.2%) | -$140.00 M(-61.9%) |
| Dec 1996 | -$367.00 M(-29.3%) | -$875.00 M(-300.2%) | -$367.00 M(+192.2%) |
| Sept 1996 | - | $437.00 M(+214.4%) | -$125.60 M(-84.7%) |
| June 1996 | - | $139.00 M(-304.4%) | -$821.40 M(-32.2%) |
| Mar 1996 | - | -$68.00 M(-89.3%) | -$1.21 B(+133.2%) |
| Dec 1995 | -$519.10 M(-938.6%) | -$633.60 M(+144.8%) | -$519.10 M(-238.4%) |
| Sept 1995 | - | -$258.80 M(+3.4%) | $375.00 M(-21.9%) |
| June 1995 | - | -$250.40 M(-140.1%) | $480.10 M(-38.0%) |
| Mar 1995 | - | $623.70 M(+139.4%) | $773.80 M(+1150.1%) |
| Dec 1994 | $61.90 M(-104.0%) | $260.50 M(-269.5%) | $61.90 M(-104.3%) |
| Sept 1994 | - | -$153.70 M(-455.0%) | -$1.45 B(-2.9%) |
| June 1994 | - | $43.30 M(-149.1%) | -$1.50 B(-12.5%) |
| Mar 1994 | - | -$88.20 M(-93.0%) | -$1.71 B(+9.2%) |
| Dec 1993 | -$1.57 B(+27.6%) | -$1.25 B(+535.8%) | -$1.57 B(+99.3%) |
| Sept 1993 | - | -$197.30 M(+15.2%) | -$786.20 M(+42.4%) |
| June 1993 | - | -$171.20 M(-406.3%) | -$552.20 M(-23.6%) |
| Mar 1993 | - | $55.90 M(-111.8%) | -$723.10 M(-41.1%) |
| Dec 1992 | -$1.23 B(+367.6%) | -$473.60 M(-1390.5%) | -$1.23 B(+99.4%) |
| Sept 1992 | - | $36.70 M(-110.7%) | -$616.00 M(-9.2%) |
| June 1992 | - | -$342.10 M(-23.8%) | -$678.40 M(+145.8%) |
| Mar 1992 | - | -$449.00 M(-424.4%) | -$276.00 M(+5.1%) |
| Dec 1991 | -$262.60 M(-47.5%) | $138.40 M(-638.5%) | -$262.60 M(-2.8%) |
| Sept 1991 | - | -$25.70 M(-142.6%) | -$270.30 M(+26.7%) |
| June 1991 | - | $60.30 M(-113.8%) | -$213.30 M(-25.4%) |
| Mar 1991 | - | -$435.60 M(-433.3%) | -$285.90 M(-42.8%) |
| Dec 1990 | -$499.90 M(-460.2%) | $130.70 M(+317.6%) | -$499.90 M(-20.7%) |
| Sept 1990 | - | $31.30 M(-354.5%) | -$630.60 M(-4.7%) |
| June 1990 | - | -$12.30 M(-98.1%) | -$661.90 M(+1.9%) |
| Mar 1990 | - | -$649.60 M | -$649.60 M |
| Dec 1989 | $138.80 M | - | - |
FAQ
- What is Pfizer annual cash flow from financing activities?
- What is the all time high annual CFF for Pfizer?
- What is Pfizer annual CFF year-on-year change?
- What is Pfizer quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Pfizer?
- What is Pfizer quarterly CFF year-on-year change?
- What is Pfizer TTM cash flow from financing activities?
- What is the all time high TTM CFF for Pfizer?
- What is Pfizer TTM CFF year-on-year change?
What is Pfizer annual cash flow from financing activities?
The current annual CFF of PFE is $26.07 B
What is the all time high annual CFF for Pfizer?
Pfizer all-time high annual cash flow from financing activities is $26.07 B
What is Pfizer annual CFF year-on-year change?
Over the past year, PFE annual cash flow from financing activities has changed by +$40.90 B (+275.72%)
What is Pfizer quarterly cash flow from financing activities?
The current quarterly CFF of PFE is -$4.64 B
What is the all time high quarterly CFF for Pfizer?
Pfizer all-time high quarterly cash flow from financing activities is $27.17 B
What is Pfizer quarterly CFF year-on-year change?
Over the past year, PFE quarterly cash flow from financing activities has changed by -$857.00 M (-22.68%)
What is Pfizer TTM cash flow from financing activities?
The current TTM CFF of PFE is -$6.58 B
What is the all time high TTM CFF for Pfizer?
Pfizer all-time high TTM cash flow from financing activities is $26.07 B
What is Pfizer TTM CFF year-on-year change?
Over the past year, PFE TTM cash flow from financing activities has changed by -$22.19 B (-142.18%)